Signal active
Organization
Contact Information
Overview
Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700x less land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis.
About
Biotechnology, Health Care, Chemical, Alternative Protein
2019
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nalu Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Chemical, Alternative Protein sector. The company focuses on Biotechnology and has secured $784.0M in funding across 64 round(s). With a team of 11-50 employees, Nalu Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Nalu Bio, raised $250.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
1
0
$12.3M
Details
4
Nalu Bio has raised a total of $12.3M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | |||
2021 | Seed | |||
2023 | Early Stage Venture | 12.0M | ||
2022 | Seed | 250.0K |
Investors
Nalu Bio is funded by 20 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Portfolia | - | FUNDING ROUND - Portfolia | 12.0M |
Nalu Bio | - | FUNDING ROUND - Nalu Bio | 12.0M |
Flybridge | - | FUNDING ROUND - Flybridge | 12.0M |
Nalu Bio | - | FUNDING ROUND - Nalu Bio | 250.0K |
Recent Activity
There is no recent news or activity for this profile.